Ling Wei
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in ⓘ
-
- Cancer-related molecular mechanisms research 13
- MicroRNA in disease regulation 6
- Cancer Genomics and Diagnostics 3
-
- RNA modifications and cancer 11
- Circular RNAs in diseases 7
- Epigenetics and DNA Methylation 6
- Co-authors
- Ming Yang (4 shared papers)Nasha Zhang (4 shared papers)Liyan Lv (3 shared papers)Xingwu Wang (3 shared papers)Yan Zheng (2 shared papers)Jujie Sun (2 shared papers)Jiandong Liu (1 shared paper)Yue Shen (1 shared paper)
- Journals
- The International Journal of Biochemistry & Cell Biology (2 papers)Nucleic Acids Research (2 papers)Frontiers in Genetics (2 papers)Molecular Cancer (2 papers)Optics Express (1 paper)
- Partner nations
- ChinaUnited StatesRomania
In The Last Decade
Ling Wei
42 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Cancer Research 738
- Molecular Biology 853
- Health, Toxicology and Mutagenesis 84
- Pulmonary and Respiratory Medicine 143
- Pollution 48
Countries citing papers authored by Ling Wei
This map shows the geographic impact of Ling Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Wei more than expected).
Fields of papers citing papers by Ling Wei
This network shows the impact of papers produced by Ling Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Wei. The network helps show where Ling Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Noncoding RNAs in gastric cancer: implications for drug resistance Hit paper breakdown → | 2020 | 351 |
| 2 | 2019 | 246 | |
| 3 | 2020 | 79 | |
| 4 | 2016 | 78 | |
| 5 | 2015 | 75 | |
| 6 | 2019 | 72 | |
| 7 | 2006 | 34 | |
| 8 | 2017 | 30 | |
| 9 | 2018 | 26 | |
| 10 | 2015 | 25 | |
| 11 | 2014 | 24 | |
| 12 | 2022 | 20 | |
| 13 | 2008 | 19 | |
| 14 | 2021 | 19 | |
| 15 | 2017 | 18 | |
| 16 | 2023 | 13 | |
| 17 | 2021 | 12 | |
| 18 | 2018 | 11 | |
| 19 | 2020 | 11 | |
| 20 | 2021 | 10 |
About Ling Wei
Ling Wei is a scholar working on Cancer Research, Molecular Biology, Neurology, Developmental Neuroscience and Genetics, having authored 43 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (11 papers), Circular RNAs in diseases (7 papers), MicroRNA in disease regulation (6 papers), Epigenetics and DNA Methylation (6 papers), Genetic Syndromes and Imprinting (5 papers), Cancer Genomics and Diagnostics (3 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Cancer Research (738 citations), Molecular Biology (853 citations), Health, Toxicology and Mutagenesis (84 citations), Pulmonary and Respiratory Medicine (143 citations) and Pollution (48 citations). Ling Wei has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Ming Yang, Nasha Zhang, Liyan Lv, Xingwu Wang, Yan Zheng, Jujie Sun, Jiandong Liu, Yue Shen, Yeyang Xu and Jibing Liu. Their work appears in journals such as The International Journal of Biochemistry & Cell Biology, Nucleic Acids Research, Frontiers in Genetics, Molecular Cancer and Optics Express.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.